Biofrontera (BFRI) News Today $0.61 0.00 (-0.57%) Closing price 04:00 PM EasternExtended Trading$0.59 -0.02 (-3.97%) As of 07:07 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock BFRI Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period What is Roth Capital's Forecast for Biofrontera Q2 Earnings?May 23, 2025 | americanbankingnews.comBiofrontera (NASDAQ:BFRI) Price Target Lowered to $2.75 at BenchmarkMay 20, 2025 | americanbankingnews.comEarnings call transcript: Biofrontera Q1 2025 sees revenue rise, stock dipsMay 18, 2025 | uk.investing.comBiofrontera Inc. faces Nasdaq delisting over share priceMay 16, 2025 | investing.comBiofrontera signals 2025 record revenue ambitions with new Ameluz patent and cost controlsMay 16, 2025 | msn.comBiofrontera Inc. (BFRI) Q1 2025 Earnings Call TranscriptMay 16, 2025 | seekingalpha.comBiofrontera Inc. (BFRI) Reports 9% Revenue Growth in Q1 2025May 16, 2025 | gurufocus.comBiofrontera Inc. Reports First Quarter 2025 Financial Results and Provides a Business Update | ...May 15, 2025 | gurufocus.comBiofrontera Inc. (BFRI) Sees Encouraging Revenue Growth in Q1 | BFRI Stock NewsMay 15, 2025 | gurufocus.comBiofrontera Inc. Reports First Quarter 2025 Financial Results and Provides a Business UpdateMay 15, 2025 | globenewswire.comBiofrontera Inc. Announces New Patent Protection on Ameluz® until 2043 and the Completion of Patient Enrollment in Phase 2b Study of Ameluz® (aminolevulinic acid HCI) Topical Gel, 10% for the Treatment of Moderate to Severe Acne VulgarisMay 15, 2025 | globenewswire.comAn Overview of Biofrontera's EarningsMay 15, 2025 | benzinga.comBiofrontera Faces Nasdaq Non-Compliance NoticeMay 14, 2025 | tipranks.comBiofrontera Inc. to Report First Quarter FY 2025 Financial Results on May 15, 2025May 6, 2025 | gurufocus.comBiofrontera Inc. to Report First Quarter FY 2025 Financial Results on May 15, 2025 | BFRI Stock NewsMay 6, 2025 | gurufocus.comBiofrontera and Almirall Launch the Hats On Challenge to Raise Awareness and Support for Actinic KeratosisMay 1, 2025 | globenewswire.comBiofrontera Inc. (NASDAQ:BFRI) Q4 2024 Earnings Call TranscriptMarch 25, 2025 | msn.comBiofrontera Inc. Reports Record Sales and Strategic AdvancesMarch 24, 2025 | tipranks.comEarnings call transcript: Biofrontera Q4 2024 sees revenue growth and strategic shiftsMarch 23, 2025 | uk.investing.comBiofrontera Full Year 2024 Earnings: Misses ExpectationsMarch 22, 2025 | finance.yahoo.comBiofrontera Inc (BFRI) Q4 2024 Earnings Call Highlights: Record Revenue Growth Amidst Financial ...March 22, 2025 | finance.yahoo.comBiofrontera Inc. Reports Record Revenue Growth in 2024March 22, 2025 | tipranks.comBiofrontera outlines 2025 growth strategies with new FDA approvals and clinical progressMarch 21, 2025 | msn.comBiofrontera Inc. (BFRI) Q4 2024 Earnings Call TranscriptMarch 21, 2025 | seekingalpha.comBiofrontera Inc. Reports Record Fiscal Year 2024 Financial Results and Provides a Business UpdateMarch 21, 2025 | globenewswire.comBiofrontera Completes Patient Enrollment In Phase 3 Study Of Ameluz For Actinic KeratosesMarch 20, 2025 | nasdaq.comBiofrontera Inc. Announces Completion of Patient Enrollment in Phase 3 Study of Ameluz® (aminolevulinic acid HCI) Topical Gel, 10% for the Treatment of Actinic Keratoses on the Extremities, Neck and TrunkMarch 18, 2025 | globenewswire.comBiofrontera Inc. to Report Fourth Quarter and Full Year 2024 Financial Results on March 21, 2025March 11, 2025 | globenewswire.comBiofrontera, Inc.January 23, 2025 | edition.cnn.comBiofrontera Inc. files to sell 5.72M shares of common stock for holdersJanuary 21, 2025 | markets.businessinsider.comBiofrontera Inc. Announces Achievement of Key Milestone In Phase 3 Study Of Ameluz®-Photodynamic Therapy (PDT) In The Treatment Of Superficial Basal Cell Carcinoma (sBCC)January 8, 2025 | globenewswire.comBiofrontera announces 100 RhodoLED XL machines placed in U.S. marketDecember 24, 2024 | markets.businessinsider.comBiofrontera Inc. Announces 100 RhodoLED® XL Machines Now Placed in US MarketDecember 23, 2024 | globenewswire.comBiofrontera Inc. to Present at The Benchmark Company's Upcoming Discovery One-on-One Investor ConferenceDecember 3, 2024 | finance.yahoo.comBiofrontera Secures $4.2M for Strategic Growth InitiativesNovember 23, 2024 | markets.businessinsider.comBiofrontera Inc. Closes a $4.2 Million Senior Secured Convertible NoteNovember 22, 2024 | globenewswire.comBiofrontera Inc. Reports Q3 2024 Earnings GrowthNovember 16, 2024 | markets.businessinsider.comBiofrontera Inc. (NASDAQ:BFRI) Q3 2024 Earnings Call TranscriptNovember 16, 2024 | msn.comBenchmark Co. Remains a Buy on Biofrontera (BFRI)November 16, 2024 | markets.businessinsider.comBiofrontera Inc (BFRI) Q3 2024 Earnings Call Highlights: Strategic Advancements Amidst Revenue ...November 15, 2024 | finance.yahoo.comBiofrontera Inc. Reports Third Quarter and Nine-Month 2024 Financial Results and Provides Business UpdateNovember 13, 2024 | globenewswire.comBiofrontera Announces Promising Phase 3 Study ResultsOctober 31, 2024 | markets.businessinsider.comBiofrontera Inc. Announces Highly Significant Results In Phase 3 Study Of Ameluz®-Photodynamic Therapy (PDT) Regarding The Treatment Of Superficial Basal Cell Carcinoma (sBCC)October 31, 2024 | globenewswire.comBiofrontera Inc. Announces Database Lock Of Phase 3 Study Of Ameluz®-Photodynamic Therapy (PDT) In The Treatment Of Superficial Basal Cell Carcinoma (sBCC)October 14, 2024 | globenewswire.comBiofrontera Inc (BFRI) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ...October 9, 2024 | finance.yahoo.comBiofrontera: FDA Approves SNDA To Increase Maximally Approved Dosage Of Ameluz - Quick FactsOctober 8, 2024 | markets.businessinsider.comFDA Approves Use of Up To Three Tubes of Biofrontera Inc.’s Ameluz (aminolevulinic acid HCI) Topical Gel, 10% In One TreatmentOctober 8, 2024 | markets.businessinsider.comFDA Approves Use of Up To Three Tubes of Biofrontera Inc.'s Ameluz (aminolevulinic acid HCI) Topical Gel, 10% In One TreatmentOctober 7, 2024 | globenewswire.comBiofrontera Second Quarter 2024 Earnings: EPS Beats Expectations, Revenues LagAugust 18, 2024 | finance.yahoo.comBiofrontera Inc. Reports Second Quarter 2024 Financial Results and Provides a Business UpdateAugust 14, 2024 | globenewswire.com Get Biofrontera News Delivered to You Automatically Sign up to receive the latest news and ratings for BFRI and its competitors with MarketBeat's FREE daily newsletter. Email Address BFRI Media Mentions By Week BFRI Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BFRI News Sentiment▼-0.360.88▲Average Medical News Sentiment BFRI News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BFRI Articles This Week▼41▲BFRI Articles Average Week Get Biofrontera News Delivered to You Automatically Sign up to receive the latest news and ratings for BFRI and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ALXO News Today CYTH News Today CLNN News Today CASI News Today ABVC News Today LSTA News Today TPST News Today ENLV News Today BCAB News Today PASG News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BFRI) was last updated on 5/29/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredAs Bitcoin supply vanishes, this Trump-aligned token could explodeBitcoin's supply is being drained at unprecedented rates, but while most investors focus solely on Bitcoin, th...Crypto 101 Media | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAIEven though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biofrontera Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Biofrontera With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BFRI Stock Free BFRI Stock Alerts